Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
05 6월 2024 - 7:00PM
Business Wire
- Diabetes management goes hands-free as Dexcom G7 now connects
directly to Apple Watch* in the U.S., giving users confidence even
when their iPhone isn’t with them†
- As the first and only CGM system that connects directly to
Apple Watch,* Dexcom G7 gives users the freedom and convenience of
real-time glucose readings on their wrist
- Direct to Apple Watch is now available to Dexcom G7 users in
the United States, United Kingdom and Ireland, with additional
markets launching later this month
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time
continuous glucose monitoring for people with diabetes, announced
today that the Dexcom G7 Continuous Glucose Monitoring (CGM) System
now connects directly to Apple Watch* in the United States. Dexcom
G7 is the first and only CGM available with Direct to Apple Watch,
offering users the freedom and convenience of real-time glucose
readings on their wrist even when their iPhone isn’t with
them.†
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240605396939/en/
Diabetes management goes hands-free as
Dexcom G7 now connects directly to Apple Watch in the US, giving
users confidence even when their iPhone isn’t with them. (Photo:
Business Wire)
“At Dexcom, our users are at the heart of everything we do.
Direct to Apple Watch has been one of our most requested features
and we’re thrilled to roll it out to Dexcom G7 users in the U.S.
and around the world,” said Jake Leach, executive vice president
and chief operating officer at Dexcom. “We’ve long believed that
people with diabetes should be able to view their CGM data where
and how they choose. Direct to Apple Watch is a testament to that,
allowing people with diabetes flexibility and choice in how they
manage their health.”
Using its own dedicated Bluetooth connection, Dexcom G7 sends
glucose information and personalized alerts right to a user’s Apple
Watch, allowing them to go for a run, enjoy a dinner out, and feel
confident leaving their iPhone behind.† Dexcom G7 is the only CGM
system that can display glucose on multiple devices simultaneously
and independently, including on a smartphone, smart watch, receiver
or connected automated insulin delivery system.‡
In addition to the benefits of using Direct to Apple Watch with
Dexcom G7, people with diabetes can track other key health metrics
that can impact glucose levels using Apple’s Activity, Cycle
Tracking, Sleep, and other health features on Apple Watch, iPhone
and iPad. All of this data is stored securely in the Health app,
where it can be viewed alongside Dexcom G7 data users choose to
store in the Health app so all of their diabetes health information
is accessible in one place. Apple products are built with strong
privacy protections and users have control over their data in the
Health app.
"Having used Direct to Apple Watch with Dexcom G7 for the last
few months, being able to glance at my wrist and see my glucose
levels in real-time has been a game changer," said Dexcom Warrior
Beth McDaniel of Northern Ireland. "For the first time since being
diagnosed, I can leave my phone at home without worrying and enjoy
my daily activities with the confidence that I have the information
I need to help keep my diabetes under control."
Direct to Apple Watch is now available to Dexcom G7 users in the
United States, United Kingdom and Ireland, with additional markets
launching later this month. To use Direct to Apple Watch, users
must have the Dexcom G7 app version 2.1, Apple Watch Series 6 or
later running watchOS 10 or later, and an iPhone running iOS 17 or
later. To learn more about Direct to Apple Watch and see a list of
compatible devices, visit www.Dexcom.com/G7.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health
through innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, Calif., and with operations across
Europe and select parts of Asia/Oceania, Dexcom has emerged as a
leader of diabetes care technology. By listening to the needs of
users, caregivers, and providers, Dexcom works to simplify and
improve diabetes management around the world. For more information
about Dexcom CGM, visit www.dexcom.com.
*Smart device sold separately. To view a list of compatible
devices, visit dexcom.com/compatibility. †Compatible smartphone is
required to pair a new Dexcom G7 sensor with a compatible Apple
Watch. To use Share/Follow the smartphone must be within 20 feet of
the Dexcom G7. ‡To learn more about insulin pump integrations and
compatibility with Dexcom CGM Systems, visit
dexcom.com/integrate.
Category: IR
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240605396939/en/
Media Contact James McIntosh 619-884-2118
james.mcintosh@dexcom.com
Investor Contact Sean Christensen 858-203-6657
sean.christensen@dexcom.com
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
DexCom (NASDAQ:DXCM)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024